Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast vs Acitretin in Moderate-to-Severe Hidradenitis Suppurativa
NCT07708480Phase 4Completed
- Sponsor
- Hayatabad Medical Complex
- Start
- Dec 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
A Phase 4 trial of apremilast in hidradenitis suppurativa (HS), sponsored by Hayatabad Medical Complex. Started Dec 2024; status: completed.
02
Drugs
apremilast
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT07708480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07708480.